Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Four finalists will make presentations on Monday and Tuesday in a review for Lantus, a diabetes drug from Aventis Pharmaceuticals, sources said.
Billings on the global account, which includes both creative and media duties, have not been determined. Sources, however, pegged them at $100 million.
The presentations will take place at the client’s U.S. headquarters in Bridgewater, N.J. The finalists include Interpublic Group’s McCann-Erickson, Omnicom Group’s TBWA Worldwide and the WPP Group team of Young & Rubicam, Burson-Marsteller and Mediaedge:cia, said sources.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in